Table 1 Baseline characteristics of the study group. Displayed values are mean ± standard deviation or median [minimum–maximum] or absolute (relative) frequencies
Age (years) | 44.2 ± 22.1 |
ISS | 45 ± 16 |
AISHead ≥ 3 (n) | 20 (55.6%) |
AISFace ≥ 3 (n) | 3 (8.3%) |
AISThorax ≥ 3 (n) | 29 (80.6%) |
AISAbdomen ≥ 3 (n) | 16 (44.4%) |
AISExtremitis ≥ 3 (n) | 25 (69.4%) |
AISExternal ≥ 3 (n) | 0 (0%) |
Complications | |
 Sepsis (n) | 3 (8.3%) |
 ARDS (n) | 8 (22.2%) |
 Pneumonia (n) | 10 (27.8%) |
 Acute kidney injury (n) | 5 (13.9%) |
 Hemofiltration (n) | 3 (8.3%) |
 Urinary tract infiltration (n) | 3 (8.3%) |
 Pancreatitis (n) | 2 (5.6%) |
 Clostridium difficile infection (n) | 1 (2.8%) |
Enzyme levels day 0 (pg/mL) | |
 MMP3 | 9594 [3068 − 35770] |
 MMP8 | 29,133 [5323 − 788304] |
 MMP9 | 1,360,006 [287278 − 4698005] |
 MMP10 | 1109 [392 − 2570] |
 MMP12 | 3852 [1609 − 6418] |
 MMP13 | 1943 [711 − 3413] |
Reference levels (pg/mL) | |
 MMP3 | 7213 [3510 − 21172] |
 MMP8 | 7161 [3628 − 49119] |
 MMP9 | 454,554 [389036 − 1351769] |
 MMP10 | 797 [419 − 2121] |
 MMP12 | 2172 [1930 − 3702] |
 MMP13 | 1926 [1040 − 3728] |